logo

For the Inventor, By the Inventor

Osaka, Japan

Yasuo Nagai

This inventor holds 7 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Takeda Chemical Industries, Inc., Eisai R&d Management Co., Ltd., Other. Active years: 1997-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yasuo Nagai. Retrieved from https://idiyas.com/inventor/yasuo-nagai-1u5d28b8

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 7 

% Patents Active = 71.4


Average Co-Inventor Count = 3.0

ph-index = 4

Forward Citations = 74(Granted Patents)


Location History:

  • Minoo, JP (2000)
  • Minoh, JP (2009)
  • Osaka, JP (1997 - 2012)

Company Filing History:

goldMedal4 out of 1,858 
 
Takeda Chemical Industries, Inc.
 patents
silverMedal3 out of 530 
 
Eisai R&d Management Co., Ltd.
 patents
bronzeMedal2 out of 834,601 
Other
 patents
where one patent can have more than one assignee

Years Active: 1997-2012

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents
1. 8173775 - Collagen-like protein CLAC, a precursor thereof, and genes encoding the same (2012-05-08),
2. 7888076 - Collagen-like protein CLAC, precursor thereof and genes encoding the same (2011-02-15),
3. 7514542 - Collagen-like protein CLAC, precursor thereof and genes encoding the same (2009-04-07),
4. 6011046 - Quinone compound, its production and use as antioxidant (2000-01-04),
5. 5654296 - Condensed heterocyclic compounds, their production and use (1997-08-05),
6. 5607939 - Condensed heterocyclic compounds, their production and use (1997-03-04),
7. 5591849 - Spiro[naphthalene-2(1H),2'-piperidine] and their use (1997-01-07),

Title: Yasuo Nagai: Innovator in Alzheimer's Disease Research

Introduction

Yasuo Nagai is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of biomedical research, particularly in the study of Alzheimer's disease. With a total of 7 patents to his name, Nagai's work has the potential to impact the diagnosis and treatment of this debilitating condition.

Latest Patents

Nagai's latest patents include groundbreaking research on a novel human collagen-like protein known as CLAC. This protein occurs in brain amyloid and has a precursor called CLAC-P. His patents detail the genes encoding these proteins, the cDNA of mouse CLAC-P, and its deduced amino acid sequence. Additionally, he has developed antibodies specific to these proteins and methods for diagnosing, treating, and preventing Alzheimer's disease using this innovative approach.

Career Highlights

Throughout his career, Yasuo Nagai has worked with notable companies in the pharmaceutical industry. He has been associated with Takeda Chemical Industries, Inc. and Eisai R&D Management Co., Ltd. His work in these organizations has allowed him to collaborate with leading experts in the field and contribute to significant advancements in medical research.

Collaborations

Nagai has collaborated with esteemed colleagues such as Kaneyoshi Kato and Takeshi Iwatsubo. These partnerships have further enriched his research and have played a crucial role in the development of his innovative patents.

Conclusion

Yasuo Nagai's contributions to Alzheimer's disease research through his patents and collaborations highlight his dedication to advancing medical science. His work continues to pave the way for new diagnostic and therapeutic strategies in the fight against this challenging disease.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…